[1]张 愉a,吕尚军b,权青云a,等.西安地区306 例原发性高血压患者与降压药物相关的基因多态性分布特征分析[J].现代检验医学杂志,2024,39(03):90-97.[doi:10.3969/j.issn.1671-7414.2024.03.015]
　ZHANG Yua,L? Shangjunb,QUAN Qingyuna,et al.Analysis of the Distribution Characteristics of Gene Polymorphism Related to Antihypertensive Drugs in 306 Patients with Essential Hypertension in Xi’an Area[J].Journal of Modern Laboratory Medicine,2024,39(03):90-97.[doi:10.3969/j.issn.1671-7414.2024.03.015]
点击复制

西安地区306 例原发性高血压患者与降压药物相关的基因多态性分布特征分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年03期
页码:
90-97
栏目:
论著
出版日期:
2024-05-15

文章信息/Info

Title:
Analysis of the Distribution Characteristics of Gene Polymorphism Related to Antihypertensive Drugs in 306 Patients with Essential Hypertension in Xi’an Area
文章编号:
1671-7414（2024）03-090-08
作者:
张 愉a; 吕尚军b; 权青云a; 王小艳a; 张晓杰a; 谈 昀c
（武警陕西省总队医院a. 老干部病区；b. 烧伤整形门诊；c. 检验与病理科，西安 710054）
Author(s):
ZHANG Yua;  L? Shangjunb;  QUAN Qingyuna;  WANG Xiaoyana;  ZHANG Xiaojiea;  TAN Yunc
（a. Wards for Officers; b. Burn Plastic Surgery Clinic; c.Department of Laboratory and Pathology,Hospital of Shaanxi Armed Police Corps, Xi’an 710054，China）
关键词:
原发性高血压; 基因型; 基因多态性; 西安地区
分类号:
R544.11；Q786
DOI:
10.3969/j.issn.1671-7414.2024.03.015
文献标志码:
A
摘要:
目的 分析西安地区原发性高血压（essential hypertension，EH）人群中9 个高血压药物相关基因的多态性分布特征，为个性化治疗提供客观依据。方法 选择2022 年1 月~2023 年12 月，在武警陕西省总队医院就诊的306例EH 患者作为研究对象，采用PCR- 熔解曲线法检测9 个高血压药物相关基因的多态性，分析其基因型及等位基因位点分布频率，并比较不同性别、年龄、高血压分级组患者基因多态性的相关情况。结果 在306 例患者中，各基因分布频率符合Hardy Weinberg 平衡（χ2=0.153~2.941, 均P > 0.05）。各基因位点突变率：SLCO1B1 c.388A>G 为77.29%，ADRB1 c.1165G>C 为73.20%，MTHFR C677T 为56.54% ，ADDl c.1378G>T 为48.37%，CYP2D6 c.100C>T为50.82%，ACE I/D 为35.13%，CYP3A5 c.806-4288C>T 为29.41%，SLCO1B1 c.521T>C 为 11.76%，AGTR1 c.1166A>C为7.68%，CYP2C9 c.1075A>C 为3.43%，CYP2C9 c.403C>T 无突变。在不同性别患者之间比较发现：男性组SLCO1B1c.388A>G 基因型及等位基因突变率高于女性组（χ2=5.221，8.237）；女性组CYP2D6 c.100C>T 基因型及等位基因突变率高于男性组（χ2=5.093，9.661）；男性组ACE I/D 等位基因型突变率高于女性组（χ2=6.118，8.022），差异具有统计学意义（均P<0.05）。老年组和中青年组间比较发现，中青年组CYP2C9 c.1075A>C，SLCO1B1 c.388A>G，CYP2D6c.100C>T 基因型与等位基因突变率均高于老年组，差异具有统计学意义（χ2=11.683，10.243；9.003，9.803；10.617，9.931，均P<0.05）。其余基因型及等位基因在不同性别及年龄组间比较，差异无统计学意义（χ2=1.321~7.733，均P>0.05）。不同高血压分级组之间各基因型及等位基因突变频率比较，差异无统计学意义(χ2=1.031~5.198，均P>0.05)。结论 西安地区抗高血压药物相关基因多态性分布与EH 患者性别、年龄有关, 降压药物基因型检测对于EH 患者的个性化用药治疗具有重要指导意义。
Abstract:
Objective To analyze the distribution characteristics of 9 hypertension drug related gene polymorphisms in the population of essential hypertension (EH) in Xi’an area, providing an objective basis for personalized treatment. Methods A total of 306 EH patients who visited the Shaanxi Provincial Armed Police Force Hospital from January 2022 to December 2023 were selected as the research subjects. The PCR melting curve method was used to detect 9 hypertension drug related gene polymorphisms, their genotype and allele distribution frequency were analyzed, and the correlations of gene polymorphism among patients of different genders, ages, and hypertension grading groups were compared. Results Among 306 patients, the distribution frequencies of each gene were consistent with Hardy Weinberg equilibrium (χ2=0.153~2.941,all P > 0.05). Mutation rates of various gene were as follows: SLCO1B1 c.388A>G, ADRB1 c.1165G>C, MTHFR C677T, ADDl c.1378G>T, CYP2D6 c.100C>T, ACE I/D, CYP3A5 c.806-4288C>T, SLCO1B1 c.521T>C, AGTR1 c.1166A>C and CYP2C9 c.1075A>C were 77.29%, 73.20%, 56.54%, 48.37%, 50.82%, 35.13%, 29.41%, 11.76%, 7.68% and 3.43%, respectively, and CYP2C9 c.403C>T had no mutation. Comparing with patients of different genders, the mutation rate of SLCO1B1 c.388A>G genotype and allele mutations in male group were higher than those in the female group（χ2=5.221,8.237), the mutation rate of CYP2D6 c.100C>T genotype and allele in the female group were higher than those in the male group（χ2=5.093,9.661), the mutation rate of ACE I/D allele in the male group was higher than that in the female group（χ2=6.118,8.032), with significant differences (all P<0.05). The mutation rates of CYP2C9 c.1075A>C, SLCO1B1 c.388A>G, CYP2D6 c.100C>T genotypes and alleles in the middle-aged and young age group were higher than those in the elderly group ,and the differences were statistically significant (χ2=11.683,10.243; 9.003,9.803;10.617,9.931, all P<0.05). There was no significant difference in the comparison of other genotypes and alleles among different gender and age groups and in the frequency of genotype and allele mutations among different hypertension grading groups （χ2=1.321~7.733,1.031~5.198,all P>0.05). Conclusion The distribution of gene polymorphisms related to antihypertensive drugs in the Xi’an area was related to the gender and age of EH patients. Thus, the genotype testing of antihypertensive drugs may have important guiding significance for personalized medication treatment of EH patients.

参考文献/References:

[1] GDB 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020,396(10258): 1204-1222.
[2] 《中国心血管健康与疾病报告2020》编写组.《中国心血管健康与疾病报告2020》要点解读[J]. 中国心血管杂志,2021,26(3):209-218. The Writing Committee of the Reporton Cardiovascular Health and Diseases in China 2020. Interpretation of report on cardiovascular health and diseases in China 2020[J]. Chinese Journal of Cardiovascular Medicine, 2021, 26 (3): 209-218.
[3] 陈丽媛. 原发性高血压患者血清Ficolin-3, CysC 和Hcy 水平与颈动脉内膜中层厚度的相关性分析[J].现代检验医学杂志, 2021, 36(4): 139-141, 151. CHEN Liyuan. Analysis on the correlation between serum Ficolin 3, Cys C and Hcy levels and carotid intima-media thickness in patients with essential hypertension[J]. Journal of Modern Laboratory Medicine, 2021, 36(4): 139-141, 151.
[4] 任凌雁, 靳倩, 廖喆, 等. 贵州原发性高血压人群相关药物基因多态性研究[J]. 重庆医学, 2019, 48(23):4017-4019, 4023. REN Lingyan, JIN Qian, LIAO Zhe, et al. Study on related gene polymorphisms of drugs in patients with essential hypertension in Guizhou area[J]. Chongqing Medicine, 2019, 48(23): 4017-4019, 4023.
[5] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018 年修订版)[J]. 中国心血管杂志,2019,24(1):24-56. Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, Chinese Medical Doctor Association Hypertension Committee,et al. 2018 Chinese guidelines for the management of hypertension[J]. Chinese Journal of Cardiovascular Medicine, 2019, 24 (1): 24-56.
[6] 冯淳, 甄拴平, 王华, 等. 降压药物基因多态性在高血压患者中的分布[J]. 检验医学与临床, 2023,20(22): 3290-3296. FENG Chun, ZHEN Shuanping, WANG Hua,et al. Distribution of antihypertensive drug gene polymorphism in patients with hypertension[J].Laboratory Medicine and Clinic, 2023, 20(22): 3290-3296.
[7] LIU Yi, KONG Xiaomu, JIANG Yongwei, et al. Association of AGTR1 A1166C and CYP2C9 3 gene polymorphisms with the antihypertensive effect of valsartan[J]. International Journal of Hypertension,2022, 2022: 7677252.
[8] PEDREROS-ROSALES C, JALIL MILAD R,LAGOS LUCERO M, et al. Efecto de las variantes de CYP2C9 sobre la dosis de losartán en hipertensos chilenos [Association between cytochrome p4502c9 polymorphisms and losartan dosing in hypertensive patients][J]. Revista Medica De Chile,2019,147(12):1527-1534.
[9] 张毅. ADRB1,ACE 基因多态性与高血压及左心室肥厚的相关性研究[D]. 南京：南京医科大学, 2021. ZHANG Yi. The relationship of gene polymorphism in beta -adrenergic receptor,angiotensin coniverting enzyme with essential hypertension and left ventricular hypertrophy [D]. Nanjing: Nanjing Medical University,2021.
[10] 王晶, 董天崴, 王爽, 等.β1- 肾上腺素受体、血管紧张素Ⅱ -1 型受体基因多态性与高寒地区高血压的关系研究[J]. 中国全科医学,2020,23(30):3823-3828. WANG Jing, DONG Tianwei, WANG Shuang,et al. Association of gene polymorphisms in β1-adrenergic receptor and angiotension Ⅱ -1 receptor with hypertension in alpine areas[J]. Chinese General Practice, 2020, 23(30): 3823-3828.
[11] MU Guangyan, XIANG Qian, ZHOU Shuang, et al. Association between genetic polymorphisms and angiotensin-converting enzyme inhibitor-induced cough: a systematic review and meta-analysis[J].Pharmacogenomics, 2019, 20(3): 189-212.
[12] CHEN Keping, XIAO Peng, LI Guochun, et al. Distributive characteristics of the CYP2C9 and AGTR1 genetic polymorphisms in Han Chinese hypertensive patients:a retrospective study[J]. BMC Cardiovascular Disorders, 2021, 21(1): 73.
[13] 付虹, 田磊. 缺血性脑卒中伴高血压病患者个体化精准治疗的研究[J]. 中国临床药理学与治疗学,2022, 27(8): 870-876. FU Hong, TIAN Lei. Individualized precision therapy for patients with ischemic stroke and hypertension[J].Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 870-876.
[14] HUANG Yun, WEN Gaiyan, LU Ya o , e t a l . CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation[J]. International Journal of Clinical Pharmacology and Therapeutics, 2017, 55(2): 109-118.
[15] 李雅静, 张瑞, 吴欣, 等. H 型高血压并发缺血性脑卒中患者MTHFR C677T 基因多态性及血清Hcy水平的相关性研究[J]. 现代检验医学杂志, 2019,34(2): 9-13. LI Yajing, ZHANG Rui, WU Xin, et al. Relationship between MTHFR C677T gene polymorphisms and serum Hcy level in H type hypertension with ischemic stroke[J]. Journal of Modern Laboratory Medicine,2019, 34(2): 9-13.
[16] 李鹏飞, 冷飞, 季忠庶. 抗高血压药物基因检测在中年高血压人群中的应用效果[J]. 中国当代医药,2019, 26(10): 49-52. LI Pengfei, LENG Fei, JI Zhongshu. Application effect of antihypertensive gene detection in middle-aged hypertensive patients[J]. China Modern Medicine,2019, 26(10): 49-52.
[17] 杜娜娜, 赵美丽. 药物基因组学指导下个体化用药对高血压患者依从性研究[J]. 甘肃科技, 2020,36(3): 109-111. DU Nana, ZHAO Meili. Study on the compliance of individualized medication in hypertensive patients under the guidance of pharmacogenomics[J]. Gansu Science and Technology, 2020, 36(3): 109-111.
[18] 赵晓娟, 权青云, 张愉. 老年高血压患者血清胱抑素C 水平与认知障碍的相关性研究[J]. 现代检验医学杂志, 2020, 35(1): 136-138. ZHAO Xiaojuan, QUAN Qingyun, ZHANG Yu. Correlation between serum systatin-C level and congnitive impairment in elderly patients with hypertension[J]. Journal of Modern Laboratory Medicine, 2020, 35(1): 136-138.
[19] RYSZ J, FRANCZYK B, RYSZ-G?RZY?SKA R, et al. Pharmacogenomics of hypertension treatment[J].International Journal of Molecular Sciences, 2020,21(13): 4709.

相似文献/References:

[1]辛毅娟a,史皆然b,杨柳a,等.ICUs分离的三种重要病原菌的耐药特性与基因型分析[J].现代检验医学杂志,2015,30(05):24.[doi:10.3969/j.issn.1671-7414.2015.05.008]
　XIN Yi-juana,SHI Jie-ranb,YANG Liua,et al.Drug Resistance and Homological Analysis of Important Clinical Bacterial Pathogens[J].Journal of Modern Laboratory Medicine,2015,30(03):24.[doi:10.3969/j.issn.1671-7414.2015.05.008]
[2]李步荣,张彤,李丽华,等.CHB患者HBV基因型及耐药突变基因联合检测临床研究[J].现代检验医学杂志,2015,30(05):40.[doi:10.3969/j.issn.1671-7414.2015.05.012]
　LI Bu-rong,ZHANG Tong,LI Li-hua,et al.Clinical Study of Combined Detection about Hepatitis B Virus Genotypes and Drug Resistant Mutation Genes in Patients with Chronic Hepatitis B[J].Journal of Modern Laboratory Medicine,2015,30(03):40.[doi:10.3969/j.issn.1671-7414.2015.05.012]
[3]于魁魁,谢凯,张潇丹,等.镇江地区儿童群体博卡病毒感染情况及基因组遗传特征[J].现代检验医学杂志,2015,30(06):67.[doi:10.3969/j.issn.1671-7414.2015.06.019]
　YU Kui-kui,XIE Kai,ZHANG Xiao-dan,et al.Human Bocavirus Infection and the Complete Genomes of the Representative Strains in Zhenjiang Area[J].Journal of Modern Laboratory Medicine,2015,30(03):67.[doi:10.3969/j.issn.1671-7414.2015.06.019]
[4]冯　婷,曾成龙,马翠玲,等.多发皮损尖锐湿疣患者不同部位取材样本HPV 基因型的差异性分析[J].现代检验医学杂志,2020,35(03):107.[doi:10.3969/j.issn.1671-7414.2020.03.028]
　FENG Ting,ZENG Cheng-long,MA Cui-ling,et al.Analysis of the Difference of HPV Genotypes among Samples Taken from Different Sites of Patients with Condyloma Acuminatum[J].Journal of Modern Laboratory Medicine,2020,35(03):107.[doi:10.3969/j.issn.1671-7414.2020.03.028]
[5]刘丽华,叶贤林,程丽娜,等.广东省河源地区献血人群隐匿性乙型肝炎病毒感染的血清学及分子生物学特征分析[J].现代检验医学杂志,2020,35(04):32.[doi:10.3969/j.issn.1671-7414.2020.04.008]
　LIU Li-hua,YE Xian-lin,CHENG Li-na,et al.Analysis of Serological and Molecular Characterization of Occult Hepatitis B Virus Infection among Blood Donors in Heyuan,Guangdong[J].Journal of Modern Laboratory Medicine,2020,35(03):32.[doi:10.3969/j.issn.1671-7414.2020.04.008]
[6]段金利.原发性高血压并发肾病患者尿微量清蛋白 / 尿肌酐比值与心率变异性的相关性研究[J].现代检验医学杂志,2021,36(03):122.[doi:10.3969/j.issn.1671-7414.2021.03.028]
　DUAN Jin-li.Study on the Correlation between Heart Rate Variability and UrinaryMicroalbumin/Urinary Creatinine Ratio in Patients with EssentialHypertension and Kidney Disease[J].Journal of Modern Laboratory Medicine,2021,36(03):122.[doi:10.3969/j.issn.1671-7414.2021.03.028]
[7]陈丽媛.原发性高血压患者血清Ficolin-3，CysC和Hcy水平与颈动脉内膜中层厚度的相关性分析[J].现代检验医学杂志,2021,36(04):139.[doi:10.3969/j.issn.1671-7414.2021.04.030]
　CHEN Li-yuan.Analysis on the Correlation between Serum Ficolin 3, Cys C and Hcy Levelsand Carotid Intima-Media Thickness in Patients with Essential Hypertension[J].Journal of Modern Laboratory Medicine,2021,36(03):139.[doi:10.3969/j.issn.1671-7414.2021.04.030]
[8]陈 诚,周 倩.原发性高血压患者血浆ARR，CTRP9 和miR-663 表达水平与靶器官损害的相关性研究[J].现代检验医学杂志,2023,38(02):63.[doi:10.3969/j.issn.1671-7414.2023.02.012 ]
　CHEN Cheng,ZHOU Qian.Study on the Relationship between the Expression of ARR, CTRP9 and miR-663 in Plasma and Target Organ Damage in Patients with Essential Hypertension[J].Journal of Modern Laboratory Medicine,2023,38(03):63.[doi:10.3969/j.issn.1671-7414.2023.02.012 ]
[9]黄媛媛,叶丽花,黄 俊,等.广西来宾市育龄人群珠蛋白生成障碍性贫血基因检测结果分析[J].现代检验医学杂志,2024,39(02):96.[doi:10.3969/j.issn.1671-7414.2024.02.018]
　HUANG Yuanyuan,YE Lihua,HUANG Jun,et al.Analysis of Gene Testing Results for Thalassemia in Childbearing-Age Population of Laibin City, Guangxi[J].Journal of Modern Laboratory Medicine,2024,39(03):96.[doi:10.3969/j.issn.1671-7414.2024.02.018]

备注/Memo

备注/Memo:
作者简介：张愉（1977-），女，学士，主治医师，研究方向：老年病学，E-mail：1583094500@qq.com。
通讯作者：谈昀（1972-）, 女，学士，主任技师，研究方向：临床化学及分子生物学研究，E-mail：1522895942@qq.com。
更新日期/Last Update: 2024-05-15